HDV vs IBB
iShares Core High Dividend ETF vs iShares Biotechnology ETF
- • HDV has the lower expense ratio at 0.08% vs 0.44% for IBB.
- • HDV pays a higher dividend yield (2.88%).
Side-by-side metrics
| Metric | HDV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.88% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $13.57B | $7.95B |
YTD return | 12.20% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.37 | 0.74 |
P/E ratio | 21.90 | 23.72 |
Last price | $26.91 | $170.10 |
Inception | — | — |
Issuer | iShares | iShares |
HDV top holdings
| XOM | Exxon Mobil Corp | 8.42% |
| CVX | Chevron Corp | 6.42% |
| JNJ | Johnson & Johnson | 5.68% |
| ABBV | AbbVie Inc | 5.44% |
| PG | Procter & Gamble Co | 4.46% |
| PM | Philip Morris International Inc | 4.17% |
| HD | The Home Depot Inc | 4.07% |
| KO | Coca-Cola Co | 3.86% |
| PGR | Progressive Corp | 3.79% |
| MRK | Merck & Co Inc | 3.77% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About HDV
HDV (iShares Core High Dividend ETF) is US high-dividend stocks with quality screen. Managed by iShares, the fund carries $13.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 2.88%. Its largest holding is Exxon Mobil Corp (XOM), which represents 8.4% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 6.1%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.